Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort

Journal of Hepatology · Published 2026-07-01 · DOI 10.1016/j.jhep.2026.06.038

Free full text

Authors (20)

George Papatheodoridis, George Dalekos, Ramazan Idilman, Vana Sypsa, Maria Buti, Jose Luis Calleja, Spilios Manolakopoulos, Edo Dongelmans, Marta Borghi, Margarita Papatheodoridi, Nikolaos Gatselis, Zeynep Melekoğlu Ellik, Marta López-Gomez, Spyros Siakavellas, Sofia Paraskevopoulou, Kostas Galanis, Özge Koç, Rafael Esteban, Harry L.A. Janssen, Pietro Lampertico

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Papatheodoridis, G., Dalekos, G., Idilman, R., et al. (2026). Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2026.06.038

Related articles